Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Omnicyte
company
About
Omnicyte is a biotechnology company that develops targeted treatments for cancer therapy.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $256K
- Industries
- Biotechnology,Health Care,Product Research
- Founded date
- Jan 1, 2012
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Omnicyte is a biotechnology company that develops targeted treatments for cancer therapy. The company develops a proprietary Immuno-Oncology Platform Technology for recombinant targeted immunomodulators, ovarian cancer indication, small cell lung cancer, and multiple additional indications.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$256K
Omnicyte has raised a total of
$256K
in funding over 2 rounds. Their latest funding was raised on
Nov 23, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 23, 2020 | Grant | $256K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Omnicyte is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
